BARDA continues to support host-based medical countermeasures that can augment traditional pathogen-based approaches to aid in triage and management of COVID-19 patients. As severe COVID-19 disease may progress to sepsis, earlier identification, and intervention along the continuum of care could improve patient outcomes.
As part of our COVID-19 response, Rapidly Deployable Capabilities, was launched to empower patients, healthcare providers and aid in triaging patients for care or aid in allocation of resources. Many of these investments leveraged technologies that were developed for sepsis or could also be used in monitoring sepsis patients.
Rapidly Deployable Capabilities portfolio
Read more about what BARDA experts had to say about sepsis and COVID-19 on the ASPR Blogs